Is GLYE or MRK a better dividend investment in 2026?

GLYE currently yields 1000000.00% with a 5% 5-year dividend growth rate. MRK yields 2.76% with 8.2% growth. The better choice depends on your goal: GLYE offers higher current income.

What is the dividend yield difference between GLYE and MRK?

GLYE has a forward dividend yield of 1000000.00% ($2.00/share annually). MRK yields 2.76% ($3.32/share annually). The yield gap is 999997.24 percentage points.

Home › Compare › GLYE vs MRK

GLYE vs MRK: Dividend Comparison 2026

GLYE yields 1000000.00% · MRK yields 2.76%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 GLYE wins by $4.7683925249533696e+36M in total portfolio value

INVESTMENT

TIME HORIZON10 years

GLYE

● Live price

1000000.00%

Share price

$0.00

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$4.7683925249533696e+36M

Annual income

$4,767,454,694,456,067,000,000,000,000,000,000,000,000,000.00

Full GLYE calculator →

MRK

Merck & Co. Inc.

● Live price

2.76%

Share price

$120.31

Annual div

$3.32

5Y div CAGR

32.7%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$56.8K

Annual income

$9,798.13

Full MRK calculator →

Portfolio growth — GLYE vs MRK

📍 GLYE pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	GLYE	MRK
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, GLYE + MRK cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

GLYE pays

MRK pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

GLYE

Annual income on $10K today (after 15% tax)

$85,000,000.00/yr

After 10yr DRIP, annual income (after tax)

$4,052,336,490,287,657,000,000,000,000,000,000,000,000,000.00/yr

MRK

Annual income on $10K today (after 15% tax)

$234.56/yr

After 10yr DRIP, annual income (after tax)

$8,328.41/yr

At 15% tax rate, GLYE beats the other by $4,052,336,490,287,657,000,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of GLYE + MRK for your $10,000?

GLYE: 50%MRK: 50%

100% MRK50/50100% GLYE

Portfolio after 10yr

$2.3841962624766848e+36M

Annual income

$2,383,727,347,228,033,600,000,000,000,000,000,000,000,000.00/yr

Blended yield

99.98%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

GLYE

No analyst data

MRK

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$128.54

+6.8% upside vs current

Range: $100.00 — $150.00

Altman Z

4.0

Piotroski

6/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

GLYE buys

MRK buys

No recent congressional trades found for GLYE or MRK in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricGLYEMRK

Forward yield	1000000.00% ✓	2.76%
Annual dividend / share	$2.00	$3.32 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	32.7% ✓
Portfolio after 10y	$4.7683925249533696e+36M	$56.8K ✓
Annual income after 10y	$4,767,454,694,456,067,000,000,000,000,000,000,000,000,000.00 ✓	$9,798.13
Total dividends collected	$4.7683311610149396e+36M	$28.9K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: GLYE vs MRK ($10,000, DRIP)

Year	GLYE Portfolio	GLYE Income/yr	MRK Portfolio	MRK Income/yr	Gap
1← crossover	$100,010,700	$100,000,000.00	$11,206	$366.19	+$100.00M → GLYE
2	$934,786,450,701	$934,679,439,252.34	$12,650	$502.35	+$934786.44M → GLYE
3	$8,165,787,108,578,292	$8,164,786,887,076,042.00	$14,407	$694.19	+$8165787108.56M → GLYE
4	$66,665,884,190,957,650,000	$66,657,146,798,751,470,000.00	$16,585	$967.82	+$66665884190957.63M → GLYE
5	$508,662,171,058,048,100,000,000	$508,590,838,561,963,700,000,000.00	$19,342	$1,363.89	+$508662171058048128.00M → GLYE
6	$3,627,235,248,428,489,700,000,000,000	$3,626,690,979,905,457,600,000,000,000.00	$22,913	$1,947.19	+$3.62723524842849e+21M → GLYE
7	$24,173,681,159,150,610,000,000,000,000,000	$24,169,800,017,434,790,000,000,000,000,000.00	$27,662	$2,823.89	+$2.417368115915061e+25M → GLYE
8	$150,567,402,861,454,640,000,000,000,000,000,000	$150,541,537,022,614,370,000,000,000,000,000,000.00	$34,159	$4,173.35	+$1.5056740286145463e+29M → GLYE
9	$876,477,100,281,847,600,000,000,000,000,000,000,000	$876,315,993,160,785,800,000,000,000,000,000,000,000.00	$43,337	$6,308.80	+$8.764771002818475e+32M → GLYE
10	$4,768,392,524,953,369,600,000,000,000,000,000,000,000,000	$4,767,454,694,456,067,000,000,000,000,000,000,000,000,000.00	$56,776	$9,798.13	+$4.7683925249533696e+36M → GLYE

GLYE vs MRK: Complete Analysis 2026

GLYE — Stock

GlyEco, Inc., a specialty chemical company, develops, manufactures, and distributes performance fluids for the automotive, commercial, and industrial markets in North America. It develops, manufactures, and markets additive packages for the antifreeze/coolant, gas patch coolant, and heat transfer industries; and METALGUARD additive package product line comprising one-step inhibitor systems to make various types of antifreeze concentrates and 50/50 coolants for automobiles, heavy-duty diesel engines, stationary engines in gas patch, and other applications, as well as METALGUARD heat transfer fluids that include propylene and ethylene glycol based light and heavy-duty fluids for various operating temperatures. It also operates a glycol re-distillation plant in West Virginia, which processes waste glycol into virgin quality recycled glycol for sale to industrial customers worldwide. GlyEco, Inc. was founded in 1996 and is based in Institute, West Virginia.

Full GLYE Calculator →

MRK — Healthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →

📬

Get this GLYE vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

GLYE vs SCHD GLYE vs JEPI GLYE vs O GLYE vs KO GLYE vs MAIN GLYE vs JNJ GLYE vs ABBV GLYE vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.